332 related articles for article (PubMed ID: 17226025)
1. Intravitreal triamcinolone acetonide in the management of cystoid macular edema in Behçet's disease.
Atmaca LS; Yalçindağ FN; Ozdemir O
Graefes Arch Clin Exp Ophthalmol; 2007 Mar; 245(3):451-6. PubMed ID: 17226025
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and complications of intravitreal injection of triamcinolone acetonide for refractory cystoid macular edema associated with intraocular inflammation.
Dong Z; Namba K; Kitaichi N; Goda C; Kitamura M; Ohno S
Jpn J Ophthalmol; 2008; 52(5):374-379. PubMed ID: 18991038
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
Bae JH; Lee CS; Lee SC
Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal triamcinolone acetonide for the treatment of cystoid macular edema secondary to Behçet disease.
Karacorlu M; Mudun B; Ozdemir H; Karacorlu SA; Burumcek E
Am J Ophthalmol; 2004 Aug; 138(2):289-91. PubMed ID: 15289142
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal triamcinolone acetonide in refractory pseudophakic cystoid macular edema: functional and anatomic results.
Boscia F; Furino C; Dammacco R; Ferreri P; Sborgia L; Sborgia C
Eur J Ophthalmol; 2005; 15(1):89-95. PubMed ID: 15751245
[TBL] [Abstract][Full Text] [Related]
6. Indocyanine-green-mediated photothrombosis (IMP) with intravitreal triamcinolone acetonide for macular edema secondary to group 2A idiopathic parafoveal telangiectasis without choroidal neovascularization: a pilot study.
Arevalo JF; Sanchez JG; Garcia RA; Wu L; Berrocal MH; Rodriguez FJ; Rodríguez A; Novoa LA; Garcia-Amaris R
Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1673-80. PubMed ID: 17619895
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal triamcinolone for the treatment of refractory macular edema in idiopathic intermediate or posterior uveitis.
Hogewind BF; Zijlstra C; Klevering BJ; Hoyng CB
Eur J Ophthalmol; 2008; 18(3):429-34. PubMed ID: 18465727
[TBL] [Abstract][Full Text] [Related]
9. Early treatment of cystoid macular edema secondary to branch retinal vein occlusion with intravitreal triamcinolone acetonide.
Yepremyan M; Wertz FD; Tivnan T; Eversman L; Marx JL
Ophthalmic Surg Lasers Imaging; 2005; 36(1):30-6. PubMed ID: 15688969
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion.
Park CH; Jaffe GJ; Fekrat S
Am J Ophthalmol; 2003 Sep; 136(3):419-25. PubMed ID: 12967793
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal and posterior subtenon triamcinolone acetonide in idiopathic bilateral uveitic macular oedema.
Choudhry S; Ghosh S
Clin Exp Ophthalmol; 2007 Nov; 35(8):713-8. PubMed ID: 17997773
[TBL] [Abstract][Full Text] [Related]
12. Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide.
Lin JM; Chiu YT; Hung PT; Tsai YY
Retina; 2007 Feb; 27(2):180-9. PubMed ID: 17290200
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.
Ip MS; Gottlieb JL; Kahana A; Scott IU; Altaweel MM; Blodi BA; Gangnon RE; Puliafito CA
Arch Ophthalmol; 2004 Aug; 122(8):1131-6. PubMed ID: 15302652
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion.
Cekiç O; Chang S; Tseng JJ; Barile GR; Del Priore LV; Weissman H; Schiff WM; Ober MD
Retina; 2005; 25(7):851-5. PubMed ID: 16205563
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
Jonas JB
Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
[TBL] [Abstract][Full Text] [Related]
16. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal triamcinolone acetonide for the management of papillophlebitis and associated macular edema.
Chang YC; Wu WC
Int Ophthalmol; 2008 Aug; 28(4):291-6. PubMed ID: 17701380
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion.
Williamson TH; O'Donnell A
Am J Ophthalmol; 2005 May; 139(5):860-6. PubMed ID: 15860292
[TBL] [Abstract][Full Text] [Related]
19. Panretinal photocoagulation and intravitreal triamcinolone acetonide for the management of proliferative diabetic retinopathy with macular edema.
Zein WM; Noureddin BN; Jurdi FA; Schakal A; Bashshur ZF
Retina; 2006 Feb; 26(2):137-42. PubMed ID: 16467667
[TBL] [Abstract][Full Text] [Related]
20. One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion.
Gregori NZ; Rosenfeld PJ; Puliafito CA; Flynn HW; Lee JE; Mavrofrides EC; Smiddy WE; Murray TG; Berrocal AM; Scott IU; Gregori G
Retina; 2006 Oct; 26(8):889-95. PubMed ID: 17031288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
